Organs-on-chips Market Size

Organs-on-chips Market Size

Organs-on-chips Market size was valued at USD 116.5 million in 2023 and is expected to record over USD 1.4 billion by 2032 driven by the increasing demand for more accurate and reliable in-vitro models of human organs for drug discovery, toxicity testing, and disease modelling.

Organs-on-chips are microfluidic devices that hold the potential to revolutionize the pharmaceutical and healthcare industries by providing more physiologically relevant R&D platforms. Moreover, this technology offers a significant benefit for potentially minimizing the need for animals in medical research, aligning with ethical practices. For instance, the Humane Society International stated that over 115 million animals are utilized for clinical testing worldwide. The strong ability to replicate human organs affordably also makes these devices promising tools in non-animal alternative testing for drug discovery.
 

However, the high cost of developing and manufacturing sophisticated devices can be a major barrier, limiting the product adoption in well-funded research institutes and large pharmaceutical companies. Regulatory challenges are also a major obstacle, as certification and approval processes for new technologies are lengthy and rigorous. Limited awareness and acceptance among the general scientific and medical communities will further hinder the market expansion.